共 58 条
[1]
Koizumi W(2008)S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215-221
[2]
Narahara H(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-697
[3]
Hara T(2015)Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer Ann Oncol 26 141-148
[4]
Bang YJ(2003)A new scoring system for peritoneal metastasis in gastric cancer Gastric Cancer 6 146-152
[5]
Van Cutsem E(2016)Regional but fatal: intraperitoneal metastasis in gastric cancer World J Gastroenterol 22 7478-7485
[6]
Feyereislova A(2009)Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study Lancet Oncol 10 1063-1069
[7]
Yamada Y(2013)Randomized phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106) Jpn J Clin Oncol 43 972-980
[8]
Higuchi K(2012)First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer Gastric Cancer 15 21-26
[9]
Nishikawa K(2018)First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake Int J Clin Oncol 23 275-280
[10]
Fujimura T(2013)Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis Gastric Cancer 16 48-55